Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck: New drugs pending approval or in late tests
Yahoo/AP
Tuesday, May 6, 2014 - 4:43pm
tags:
Merck, approvals
Can Bristol-Myers Squibb Make a Comeback in 2014?
Motley Fool
Tuesday, May 6, 2014 - 4:38pm
tags:
Bristol-Myers Squibb
AstraZeneca Lays Out Sales Targets to Fight Pfizer Bid
TheStreet.com
Tuesday, May 6, 2014 - 11:10am
tags:
Pfizer, AstraZeneca, M&A
Forest founder, CEO set for $100M-plus payoff from Actavis buyout
Fierce Pharma
Tuesday, May 6, 2014 - 10:50am
tags:
Forest Labs, Actavis, M&A, Howard Solomon
Up, up, up: After Allergan offer, would-be buyer Ackman reaps $1.2B in gains
Fierce Pharma
Tuesday, May 6, 2014 - 10:49am
tags:
Allergan, Valeant Pharmaceuticals, Bill Ackman
Pain Therapeutics Reports Q1 2014 Financial Results
Yahoo
Tuesday, May 6, 2014 - 10:47am
tags:
earnings, Pain Therapeutics
Zoetis 1Q earnings climb 11 pct, forecast backed
Yahoo/AP
Tuesday, May 6, 2014 - 10:46am
tags:
earnings, Zoetis
Wider-than-Expected Loss at Pacira, Revs Up
Yahoo/Zacks.com
Tuesday, May 6, 2014 - 10:45am
tags:
Pacira, earnings
AstraZeneca Makes Case Against Pfizer’s Bid
NY Times, NY
Tuesday, May 6, 2014 - 10:23am
tags:
Pfizer, M&A, AstraZeneca
In fight with Pfizer, AstraZeneca promises sales surge - eventually
Yahoo/Reuters
Tuesday, May 6, 2014 - 9:53am
tags:
Pfizer, AstraZeneca, M&A
Major Acquisitions Now A Necessary Part Of Pfizer's Future Strategy
Forbes
Tuesday, May 6, 2014 - 9:22am
tags:
Pfizer, M&A, AstraZeneca, Wyeth, R&D
Astra gets lift in Pfizer fight as U.S. okays heart pill
Reuters
Tuesday, May 6, 2014 - 9:11am
tags:
Pfizer, AstraZeneca, FDA, fish oil, Epanova
Pfizer’s Breakup Options Shift Even With AstraZeneca Bid
Bloomberg
Tuesday, May 6, 2014 - 9:10am
tags:
Pfizer, AstraZeneca, restructuring, M&A
Bayer to Buy Merck Consumer-Health Unit for $14.2 Billion
Bloomberg
Tuesday, May 6, 2014 - 9:09am
tags:
Bayer, Merck, consumer health, DTC, M&A
Bristol-Myers' armed antibody partner Ambrx shoots for an $86M IPO
Fierce Biotech
Monday, May 5, 2014 - 5:15pm
tags:
IPOs, Bristol-Myers Squibb, Ambrx
Merck proposal to sell Singulair without a prescription hits resistance
Fierce Pharma
Monday, May 5, 2014 - 5:08pm
tags:
Merck, Singulair, OTC
Pfizer’s Pipeline: 2 Drugs That May Drive Future Revenues
Wall St Cheat Sheet
Monday, May 5, 2014 - 5:06pm
tags:
Pfizer, palbociclib, breast cancer, RN316
Acorda Down on Plumiaz CRL
Yahoo/Zacks.com
Monday, May 5, 2014 - 5:05pm
tags:
Acorda Therapeutics, Plumiaz, epilepsy
Paging the Doctor: Is There a Cure for Pfizer?
Wall St Cheat Sheet
Monday, May 5, 2014 - 5:03pm
tags:
Pfizer, earnings, AstraZeneca
Gilead Sciences - Sovaldi's Pricing In A New Perspective
Seeking Alpha
Monday, May 5, 2014 - 5:02pm
tags:
Gilead Sciences, Sovaldi, hepatitis C

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.